Kyverna Therapeutics, Inc. Lawsuit Submission Form
Company: Kyverna Therapeutics, Inc.
Ticker: (NASDAQ) KYTX
Deadline
Passed
Lead Plaintiff Deadline: February 07, 2025
Every year, thousands of shareholders miss deadlines to receive settlement funds. Make sure you don’t. Sign up for case alerts.
To receive more detailed alerts provide your information below.
Request Case Alerts
Allegations
The filed complaint alleges that Kyverna Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the strategy to best accomplish the IPO; (ii) the terms of the IPO, including the price at which Kyverna’s common stock would be sold; (iii) the language to be used in the Offering Documents; (iv) what disclosures about Kyverna would be made in the Offering Documents; and (v) what responses would be made to the SEC in connection with its review of the Offering Documents. As a result of those constant contacts and communications between the underwriter defendants’ representatives and Kyverna’s management, directors, and lawyers, at a minimum, the underwriterd defendants should have known of Kyverna’s undisclosed then-existing problems and plans, and the Offering Document’s materially inaccurate, misleading, and incomplete statements and omissions, as detailed herein.